Who are Rocket Pharmaceuticals, Inc.'s main suppliers?

Rocket Pharmaceuticals, Inc. (RCKT) key suppliers include: REGENXBIO Inc., CONTRACT-MANUFACTURING-ORGANIZATIONS, RCKTW. View the full supplier network at chainsifter.com/chain/RCKT.

Who are Rocket Pharmaceuticals, Inc.'s major customers?

Rocket Pharmaceuticals, Inc. (RCKT) key customers include: BUYER, CANTOR-FITZGERALD-CO, CIRM, RCKTW, PRESENTATION-ROCKET-PHARMACEUTICALS-INC. View the full customer network at chainsifter.com/chain/RCKT.

What sector is Rocket Pharmaceuticals, Inc. in?

Rocket Pharmaceuticals, Inc. (RCKT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Rocket Pharmaceuticals, Inc. Suppliers, Customers & Supply Chain (RCKT)

3Suppliers

5Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Rocket Pharmaceuticals, Inc. (RCKT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

12Total relationships

4Distinct source URLs

9High confidence

0.853Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Rocket Pharmaceuticals, Inc. Suppliers

Ticker	Name	Confidence	Evidence
RGNX	REGENXBIO Inc.	92%	Reciprocal relationship from RGNX graph: Reciprocal relationship from RCKT graph: Reciprocal relationship from RGNX graph: Reciprocal relationship from RCKT graph: Reciprocal relationship from RGNX g…
CONTRACT-MANUFACTURING-ORGANIZATIONS	CONTRACT-MANUFACTURING-ORGANIZATIONS	90%	we plan to pursue multiple options including direct manufacturing as well as outsourcing production of the active pharmaceutical (drug substance) ingredients and final drug product manufacturing (dru…
RCKTW	RCKTW	72%	Reciprocal relationship from RCKTW graph: Reciprocal relationship from RCKT graph: Reciprocal relationship from RCKTW graph: Reciprocal relationship from RCKT graph: Reciprocal relationship from RCKT…

Rocket Pharmaceuticals, Inc. Customers

Ticker	Name	Confidence	Evidence
BUYER	BUYER	92%	Pursuant to the PRV APA, the buyer has agreed to pay the Company $180 million, payable in cash, upon the closing of the sale.
CANTOR-FITZGERALD-CO	CANTOR-FITZGERALD-CO	92%	10.1 Sales Agreement, dated March 10, 2026, by and between the Company and Cantor Fitzgerald & Co.
CIRM	CIRM	92%	Through March 31, 2026, the Company has received total RP-A501 grants of $ 5.0 million from CIRM.
RCKTW	RCKTW	72%	Reciprocal relationship from RCKTW graph: egulatory requirements, including regulation of our current or any other future product candidates by the U.S. Food and Drug Administration (“FDA”); • the ti…
PRESENTATION-ROCKET-PHARMACEUTICALS-INC	PRESENTATION-ROCKET-PHARMACEUTICALS-INC	62%	) ( 261 ) Purchases of property and equipment ( 5,862 ) ( 16,436 ) ( 8,358 ) Net cash provided by/(used in) investing activities 131,706 ( 98,066 ) ( 69,326 ) Financing activities: Issuance of common…

Rocket Pharmaceuticals, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
RCKT-DEBT-12074	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2023-12-31.
RCKT-DEBT-12073	Warrants outstanding: 7051	90%	xbrl warrant detail from xbrl 2025-12-31.
RCKT-DEBT	Debt stack $24.8M	90%	Market cache reports total debt of $24.8M.

Rocket Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Rocket Pharmaceuticals, Inc..

Rocket Pharmaceuticals, Inc. Ownership

Holder	Name	Confidence	Evidence
RCKT-OWNER-RTW-INVESTMENTS-LP	RTW INVESTMENTS, LP	90%	13F overlay lists RTW INVESTMENTS, LP as top holder; 200 tracked holders.

Rocket Pharmaceuticals, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
RCKTW	ROCKET PHARMACEUTICALS, INC.	100.00	1	['customer', 'supplier']
RGNX	REGENXBIO Inc.	100.00	1	['supplier']
CIRM	CIRM	63.48	1	['receiving']
BUYER	BUYER	63.48	1	['receiving']
ABBV	AbbVie Inc.	50.00	2
OTLK	Outlook Therapeutics, Inc.	50.00	2
HHH	Howard Hughes Holdings Inc.	50.00	2
TNYA	Tenaya Therapeutics, Inc.	50.00	2
REGN	Regeneron Pharmaceuticals, Inc.	50.00	2
FDMT	4D Molecular Therapeutics, Inc.	50.00	2
DNLI	Denali Therapeutics Inc.	50.00	2
KUST	Kustom Entertainment, Inc.	50.00	2
KIDZ	Classover Holdings, Inc.	50.00	2
SRPT	Sarepta Therapeutics, Inc.	50.00	2
TSHA	Taysha Gene Therapies, Inc.	50.00	2
MLP	Maui Land & Pineapple Company, Inc.	50.00	2
SONM	DNA X, Inc.	50.00	2
PTCT	PTC Therapeutics, Inc.	50.00	2
RARE	Ultragenyx Pharmaceutical Inc.	50.00	2
AHRT	AH REALTY TRUST INC	50.00	2

Rocket Pharmaceuticals, Inc. Supply Chain